Elite Diagnostic Limited (JMSE:ELITE)

Market Cap	544.24M +10.8%
Revenue (ttm)	860.95M +1.2%
Net Income	50.29M +118.4%
EPS	0.14 +118.4%
Shares Out	353.40M
PE Ratio	10.82
Forward PE	n/a
Dividend	0.01 (0.63%)
Ex-Dividend Date	n/a

Volume	200
Average Volume	122,332
Open	n/a
Previous Close	1.250
Day's Range	1.540 - 1.540
52-Week Range	1.250 - 2.000
Beta	-0.07
RSI	53.24
Earnings Date	May 13, 2026

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company medical imaging services, including CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It also provides interventional procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In fiscal year 2025, Elite Diagnostic's revenue was 853.82 million, an increase of 3.96% compared to the previous year's 821.28 million. Earnings were 32.02 million, an increase of 22.44%.